Wenjun Ju, PhD
Research Scientist
Internal Medicine
[email protected]

Available to mentor
Wenjun Ju, PhD
Research Scientist
  • Qualifications
  • Center Memberships
  • Recent Publications
    • Qualifications
    • TGF Beta Signaling in Kidney Disease
      Albert Einstein College of Medicine, Medicine, 2004
    • PhD
      University of Braunschweig + National Biotechnology Center (GBF), Braunschweig, 1999
    • MS
      Beijing Normal University, Beijing, 1994
    • BA
      Beijing Normal University, Beijing, 1991
    Center Memberships
    • Center Member
      MM-PKUHSC Joint Institute
    • Center Member
      Center for Computational Medicine and Bioinformatics
    • Center Member
      Global REACH
    • Center Member
      Caswell Diabetes Institute
    Recent Publications See All Publications
    • Journal Article
      WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease.
      Cohen C, Mhaidly R, Croizer H, Kieffer Y, Leclere R, Vincent-Salomon A, Robley C, Anglicheau D, Rabant M, Sannier A, Timsit M-O, Eddy S, Kretzler M, Ju W, Mechta-Grigoriou F. Nat Commun, 2024 Jan 25; 15 (1): 743 DOI:10.1038/s41467-024-44886-z
      PMID: 38272907
    • Journal Article
      Towards Risk Stratification in Clinical Care for IgA Nephropathy: Genetic Risk Scores
      Berthier CC, Ju W. Phenomics, DOI:10.1007/s43657-024-00184-8
    • Journal Article
      Association of urinary EGF, FABP3, and VCAM1 levels with the progression of early diabetic kidney disease
      Keller F, Denicolò S, Leierer J, Kruus M, Heinzel A, Kammer M, Ju W, Nair V, Burdet F, Ibberson M, Menon R, Otto E, Choi YJ, Pyle L, Ladd P, Bjornstad PM, Eder S, Rosivall L, Mark PB, Wiecek A, Heerspink HJL, Kretzler M, Oberbauer R, Mayer G, Perco P. Kidney & Blood Pressure Research, 1 - 21. DOI:10.1159/000542267
    • Journal Article
      Association of Urinary Epidermal Growth Factor with Kidney Outcomes and Effects of SGLT2 Inhibition: Results from the CANVAS and CREDENCE Trials
      Moedt E, Koshino A, Jongs N, Ju W, Hansen MK, Arnott CG, Neal B, Bakker SJL, Heerspink HJL. Journal of the American Society of Nephrology, 2024 Oct; 35 (10S): 10.1681/asn.2024mdp2zx6k DOI:10.1681/asn.2024mdp2zx6k
    • Journal Article
      Identification of Urinary Biomarkers for Outcome-Associated Digital Pathology Descriptors in Patients with Nephrotic Syndrome
      Nair V, Hodgin JB, Fermin D, Lee E, Barisoni L, Kretzler M, Ju W. Journal of the American Society of Nephrology, 2024 Oct; 35 (10S): 10.1681/asn.20248ax66pn1 DOI:10.1681/asn.20248ax66pn1
    • Journal Article
      Predicting Calcineurin Inhibitor Response in Glomerular Diseases
      Eddy S, Helmuth M, McCown PJ, Nair V, Boys CM, Hartman JR, Larkina M, Ju W, Saez-Rodriguez J, Mariani LH, Kretzler M. Journal of the American Society of Nephrology, 2024 Oct; 35 (10S): 10.1681/asn.2024t4wfszbh DOI:10.1681/asn.2024t4wfszbh
    • Journal Article
      Unraveling the Mechanism of SGLT2 Inhibitors Using Urinary Proteomics in Patients with Diabetic Kidney Disease
      De la Rambelje MA, Nair V, Jongs N, Hansen MK, Voors AA, Kretzler M, Ju W, Heerspink HJL. Journal of the American Society of Nephrology, 2024 Oct; 35 (10S): 10.1681/asn.2024x1csyxb4 DOI:10.1681/asn.2024x1csyxb4
    • Journal Article
      Urinary Clusterin as a Pharmacodynamic Response Biomarker for the Endothelin Receptor Antagonist Atrasentan
      Ju W, Nair V, Vart P, Smeijer JD, Larkina M, Shedden K, Lee E, Hartman JR, Bitzer M, Duffin KL, Gomez MF, Alpers CE, Kretzler M, Heerspink HJL. Journal of the American Society of Nephrology, 2024 Oct; 35 (10S): 10.1681/asn.20245rkc0hd7 DOI:10.1681/asn.20245rkc0hd7